Kodiak Sciences Inc (NASDAQ:KOD)
| 57.80 Delayed Data As of Jan 21 |  -2.64 / -4.37%Today’s Change | 56.19 Today|||52-Week Range 171.21 | -31.82% Year-to-Date |
Latest KOD News | Press Releases
No recent news for Kodiak Sciences Inc.
Today’s Trading
| Previous close | 60.44 |
| Today’s open | 65.37 |
| Day’s range | 56.37 - 67.05 |
| Volume | 38,940 |
| Average volume (3 months) | 246,655 |
| Market cap | $3.4B |
Data as of 4:00pm ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -132.53% |
| Earnings growth (this year) | -49.87% |
| Earnings growth (next 5 years) | +57.40% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.87 |
Financials
| Next reporting date | March 31, 2022 |
| EPS forecast (this quarter) | -$1.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$133.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Palo Alto, California |
Forecasts
